Ciniero G, Gentile F, Elmenoufy AH, Cros-Perrial E, West FG, Weinfeld M, Deriu MA, Jordheim LP, Tuszynski JA. Targeting cancer drug resistance by modulation of ERCC1-XPF and p53 activity. Biomedical Sci Eng [Internet]. 2021 Sep. 29 [cited 2024 Nov. 22];2(1). Available from: https://www.pagepress.org/technology/bse/article/view/164